CSL Limited

ASX (AUD): CSL Limited (CSL)

Last Price

270.25

Today's Change

-3.17 (1.15%)

Day's Change

270.25 - 273.87

Trading Volume

854,599

Overview

Market Cap

130 Billion

Shares Outstanding

484 Million

Avg Volume

577,307

Avg Price (50 Days)

280.13

Avg Price (200 Days)

289.85

PE Ratio

30.68

EPS

8.81

Earnings Announcement

11-Feb-2025

Previous Close

273.42

Open

273.38

Day's Range

270.25 - 273.87

Year Range

265.14 - 313.55

Trading Volume

854,599

Price Change Highlight

1 Day Change

-1.16%

5 Day Change

-2.91%

1 Month Change

-2.29%

3 Month Change

-8.12%

6 Month Change

-12.59%

Ytd Change

-3.89%

1 Year Change

-6.98%

3 Year Change

2.92%

5 Year Change

-12.40%

10 Year Change

220.05%

Max Change

32591.40%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment